Shear stress-independent binding of von Willebrand factor-type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearance

被引:32
作者
Wohner, N. [1 ]
Legendre, P. [1 ,2 ]
Casari, C. [1 ]
Christophe, O. D. [1 ,2 ]
Lenting, P. J. [1 ,2 ]
Denis, C. V. [1 ,2 ]
机构
[1] INSERM, U1176, F-94276 Le Kremlin Bicetre, France
[2] Univ Paris Sud, UMR S 1176, F-94275 Le Kremlin Bicetre, France
关键词
half-life; LDL-receptor related proteins; protein-protein interaction domains; von Willebrand disease; von Willebrand factor; RECEPTOR-RELATED PROTEIN; DISEASE TYPE 2B; FACTOR-DEFICIENT MICE; IN-VIVO; THROMBOCYTOPENIA; MACROPHAGES; SURVIVAL; MUTATION; CONTRIBUTES; PROPEPTIDE;
D O I
10.1111/jth.12885
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Backgroundvon Willebrand factor (VWF) is cleared in a shear stress- and macrophage-dependent manner by LRP1. von Willebrand disease (VWD)-type 2B mutants are endocytosed more efficiently than wild-type (wt)-VWF by macrophages. ObjectiveTo investigate if VWD-type 2B mutations in the VWF A1-domain affect LRP1 binding and LRP1-dependent clearance. MethodsRecombinant Fc-tagged A1 domain (A1-Fc, A2-Fc, A3-Fc) and full-length VWF (wt or mutants thereof) were tested for binding to LRP1 or a recombinant fragment thereof in a static immunosorbent assay. Mutant and wt-VWF were also compared for clearance in mice lacking macrophage LRP1 (macLRP1(-)) and control mice (macLRP1(+)). ResultsWe found that A1-Fc but not A2-Fc or A3-Fc binds dose-dependently to LRP1. Binding of A1-Fc to LRP1 was markedly enhanced by the VWD-type 2B mutation p.V1316M. As expected, full-length wt-VWF was unable to bind LRP1 under static conditions unless ristocetin was added. In contrast, the presence of the p.V1316M or p.R1306Q mutation induced spontaneous binding to LRP1 without the need for ristocetin or shear stress. Both mutants were cleared more rapidly than wt-VWF in control macLRP1(+) mice. Surprisingly, deletion of macrophage LRP1 abrogated the increased clearance of the VWF/p.R1306Q and VWF/p.V1316M mutant. ConclusionThe VWF A1-domain contains a binding site for LRP1. Certain VWD-type 2B mutations relieve the need for shear stress to induce LRP1 binding. Enhanced LRP1 binding coincides with a reduced survival of VWF/p.R1306Q and VWF/p.V1316M. Our data provide a rationale for reduced VWF levels in at least some VWD-type 2B patients.
引用
收藏
页码:815 / 820
页数:6
相关论文
共 30 条
  • [1] Identification of amino acid residues essential for heparin binding by the A1 domain of human von Willebrand factor
    Adachi, T
    Matsushita, T
    Dong, ZY
    Katsumi, A
    Nakayama, T
    Kojima, T
    Saito, H
    Sadler, JE
    Naoe, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 339 (04) : 1178 - 1183
  • [2] Clearance of von Willebrand factor
    Casari, C.
    Lenting, P. J.
    Wohner, N.
    Christophe, O. D.
    Denis, C. V.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 202 - 211
  • [3] von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin αIIbβ3
    Casari, Caterina
    Berrou, Eliane
    Lebret, Marilyne
    Adam, Frederic
    Kauskot, Alexandre
    Bobe, Regis
    Desconclois, Celine
    Fressinaud, Edith
    Christophe, Olivier D.
    Lenting, Peter J.
    Rosa, Jean-Philippe
    Denis, Cecile V.
    Bryckaert, Marijke
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (12) : 5071 - 5081
  • [4] Accelerated uptake of VWF/platelet complexes in macrophages contributes to VWD type 2B-associated thrombocytopenia
    Casari, Caterina
    Du, Vivian
    Wu, Ya-Ping
    Kauskot, Alexandre
    de Groot, Philip G.
    Christophe, Olivier D.
    Denis, Cecile V.
    de Laat, Bas
    Lenting, Peter J.
    [J]. BLOOD, 2013, 122 (16) : 2893 - 2902
  • [5] Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia
    Casonato, Alessandra
    Gallinaro, Lisa
    Cattini, Maria Grazia
    Pontara, Elena
    Padrini, Roberto
    Bertomoro, Antonella
    Daidone, Viviana
    Pagnan, Antonio
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (08): : 1366 - 1372
  • [6] Shear stress is required for the endocytic uptake of the factor VIII-von Willebrand factor complex by macrophages
    Castro-Nunez, L.
    Dienava-Verdoold, I.
    Herczenik, E.
    Mertens, K.
    Meijer, A. B.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (09) : 1929 - 1937
  • [7] VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease
    Eikenboom, Jeroen
    Federici, Augusto B.
    Dirven, Richard J.
    Castaman, Giancarlo
    Rodeghiero, Francesco
    Budde, Ulrich
    Schneppenheim, Reinhard
    Batlle, Javier
    Canciani, Maria Teresa
    Goudemand, Jenny
    Peake, Ian
    Goodeve, Anne
    [J]. BLOOD, 2013, 121 (12) : 2336 - 2339
  • [8] Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with vonWillebrand disease type 2B: a cohort study of 67 patients
    Federici, Augusto B.
    Mannucci, Pier M.
    Castaman, Giancarlo
    Baronciani, Luciano
    Bucciarelli, Paolo
    Canciani, Maria T.
    Pecci, Alessandro
    Lenting, Peter J.
    De Groot, Philip G.
    [J]. BLOOD, 2009, 113 (03) : 526 - 534
  • [9] Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex
    Fredrickson, BJ
    Dong, JF
    McIntire, LV
    López, JA
    [J]. BLOOD, 1998, 92 (10) : 3684 - 3693
  • [10] Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival
    Haberichter, Sandra L.
    Balistreri, Michael
    Christopherson, Pamela
    Morateck, Patricia
    Gavazova, Stefana
    Bellissimo, Daniel B.
    Manco-Johnson, Marilyn J.
    Gill, Joan Cox
    Montgomery, Robert R.
    [J]. BLOOD, 2006, 108 (10) : 3344 - 3351